Pang Lingling, Jiang Tingshu, Liu Xueping, Li Zhan, Zou Shenchun, Yu Pengfei
Department of Pulmonary and Critical Care Medicine, Yantai Yuhuangding Hospital, Yantai, China.
J Thorac Dis. 2020 Dec;12(12):7666-7674. doi: 10.21037/jtd-2020-abpd-002.
Pulmonary lymphangitic carcinomatosis (PLC) is characterized by malignant infiltration into lung lymphatic channels from a primary site and is often observed in advanced malignant tumors. This study aimed to evaluate the diagnostic yield of transbronchial lung cryobiopsy in PLC guided by radial endobronchial ultrasound and virtual bronchoscopic navigation (VBN).
This prospective study enrolled 40 patients with clinical and radiologic features indicating PLC. The radial endobronchial ultrasound probe was initially advanced to the region of interest of the desired lobe near the pleura with guidance by VBN. Transbronchial lung biopsy and transbronchial lung cryobiopsy were both performed in the same ROI of all patients with the obtained samples being sent to the pathology laboratory for diagnostic analysis. Procedural complications were recorded.
The average number of transbronchial lung biopsy and transbronchial lung cryobiopsy specimens were 4 (3 to 6) and 2 (1 to 3), respectively (t=10.43, P<0.01), with the corresponding mean diameters per biopsy being 3.7 and 8.7 mm (t=12.37, P<0.01). The diagnostic yields of transbronchial lung biopsy and transbronchial lung cryobiopsy were 70% (28/40) and 92.5% (37/40), respectively. The final positive predictive values of transbronchial lung cryobiopsy and transbronchial lung biopsy for PLC were 94.4% (34/36) and 77.8% (28/36), respectively (χ=23.94, P<0.01). Further, 52.2% (12/23) and 81.5% (22/27) of the patients in the transbronchial lung biopsy and transbronchial lung cryobiopsy groups, respectively, were diagnosed with non-small lung cancer after further molecular analysis (χ=19.56, P<0.01). Only 2 (5%) cases presented postoperative pneumothorax. Moreover, 0 (0%), 3 (7.5%), and 17 (42.5%) patients presented severe, moderate, and mild bleeding, respectively. There were no other adverse events or deaths.
Transbronchial lung cryobiopsy with the guidance of radial endobronchial ultrasound and VBN without fluoroscopy has a good diagnostic yield for PLC; moreover, it allows one to obtain adequate and intact tissue samples for further molecular analysis.
肺淋巴管癌病(PLC)的特征是恶性肿瘤从原发部位浸润至肺淋巴管,常见于晚期恶性肿瘤。本研究旨在评估在径向支气管内超声和虚拟支气管镜导航(VBN)引导下经支气管肺冷冻活检对PLC的诊断价值。
本前瞻性研究纳入了40例具有PLC临床和影像学特征的患者。首先在VBN引导下,将径向支气管内超声探头推进至目标肺叶靠近胸膜的感兴趣区域。对所有患者在同一感兴趣区域进行经支气管肺活检和经支气管肺冷冻活检,并将获取的样本送至病理实验室进行诊断分析。记录操作并发症。
经支气管肺活检和经支气管肺冷冻活检标本的平均数量分别为4(3至6)块和2(1至3)块(t = 10.43,P < 0.01),每次活检标本的相应平均直径分别为3.7 mm和8.7 mm(t = 12.37,P < 0.01)。经支气管肺活检和经支气管肺冷冻活检的诊断率分别为70%(28/40)和92.5%(37/40)。经支气管肺冷冻活检和经支气管肺活检对PLC的最终阳性预测值分别为94.4%(34/36)和77.8%(28/36)(χ = 23.94,P < 0.01)。此外,经支气管肺活检组和经支气管肺冷冻活检组分别有52.2%(12/23)和81.5%(22/27)的患者在进一步分子分析后被诊断为非小细胞肺癌(χ = 19.56,P < 0.01)。仅2例(5%)出现术后气胸。此外,分别有0(0%)、3例(7.5%)和17例(42.5%)患者出现严重、中度和轻度出血。无其他不良事件或死亡病例。
在无荧光透视的情况下,在径向支气管内超声和VBN引导下进行经支气管肺冷冻活检对PLC具有良好的诊断价值;此外,它能获取足够且完整的组织样本用于进一步分子分析。